Hypertrophic Cardiomyopathy Clinical Trials
Feel free to call or e-mail the Knight Cardiovascular Institute research team at 503-418-1964 or by emailing firstname.lastname@example.org. You will then be forwarded to the appropriate research team member who will be able to see if you qualify for any of the clinical trials being offered at OHSU.
You can also find all the of heart failure clinical trials, that are currently enrolling patients, below.
Clinical Trial Name
|HCM Pilot Study: Hypertrophic Cardiomyopathy Pilot Study||Larisa Tereshchenko, MD PhD||Stephen Heitner, MD||IRB00015049|
|LIVE-HCM/LIVE-LQTS: Exercise in Genetic Cardiovascular Conditions||Stephen Heitner, MD||Charles Henrikson, MD / Eric Stecker, MD / Katherine Bischof, PA-C / Meghan Chirpich Mannello, CGC / Seshadri Balaji, MD / Sriram Ravi, MD / Thomas Dewland, MD||IRB00012026|
|MAVERICK-HCM: A Randomized, Double-blind, Pacebo-controlled, Concentration-guided, Exploratory Study of Mavacamten (MYK-461) in Patients with Symptomatic Non-obstructive Hypertrophic Cardiomyopathy (nHCM) and Preserved Left Ventricular Ejection Fraction||Stephen Heitner, MD||Babak Nazer, MD / Erin Boehm, MD / Katherine Bischof, PA-C / Lidija Breznikar McGrath, MD / Michael Shapiro, MD / Mrinal Yadava, MD / Ryan Van Woerkom, MD / Steven Mansoor, MD / Thomas Dewland, MD / Vaughn Tuchy, MD|